Science
Mechanism of Action
This dual-action ingredient functions as a potent tyrosinase inhibitor to interrupt melanin synthesis while simultaneously regulating sebum production and inhibiting P. acnes growth. Furthermore, the peptide moiety is engineered to stimulate extracellular matrix remodeling, addressing structural integrity to reduce the depth of fine lines and improve overall skin texture.
Research
Clinical Evidence
Medium confidence5%
Key findings
- 01 Binotec Co., Ltd. Patent US11452679B2 (2022) demonstrated significant melanin inhibition and wrinkle improvement via nanoethosome delivery systems.
- 02 Clinical testing of Acnoheal complex confirmed therapeutic efficacy in reducing sebum output and calming inflammatory markers in acne-prone subjects.
Transparency
Dusting Analysis
Due to its complex synthesis and high cost, this ingredient is frequently included in formulations at sub-therapeutic levels (below 1%) purely for marketing claims. Therapeutic benefits for pigmentation and acne are typically observed at concentrations of 1% or higher in aqueous complexes.
The Formula
Formulation
Stability
Optimal stability is achieved through encapsulation in liposomes or ethosomes, which protect the peptide chain from degradation. Formulation requires a near-neutral pH environment.
Synergies
- Niacinamide
- Hyaluronic Acid
- Centella Asiatica
Conflicts
- Strong acids (L-Ascorbic Acid, Glycolic Acid)
- Strong bases
- Strong oxidizing agents
Safety
Safety Profile
While not yet formally reviewed by the CIR, it is characterized by low irritancy and is currently utilized in dermatological products specifically designed for sensitive skin and hypoallergenic profiles.
Your Skin
Skin Compatibility
Our Assessment
Verdict
An innovative multi-tasking peptide that excels in simultaneous pigment correction and sebum regulation when formulated at active concentrations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources